Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

ClinicalTrials.gov ID: NCT00087087

Public ClinicalTrials.gov record NCT00087087. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 29, 2026, 3:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation Of Pemetrexed (ALIMTA LY231514, IND #40061) In The Treatment Of Recurrent Or Persistent Platinum-Resistant Ovarian Or Primary Peritoneal Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as pemetrexed disodium, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well pemetrexed disodium works in treating patients with recurrent or persistent ovarian epithelial cancer or primary peritoneal cancer.

Study identification

NCT ID
NCT00087087
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
51 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Nov 30, 2006
Completion
Not listed
Last update posted
Feb 13, 2014

Started 2004

United States locations

U.S. sites
35
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Hinsdale Hematology Oncology Associates Hinsdale Illinois 60521 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
West Michigan Cancer Center Kalamazoo Michigan 49007-3731 —
CCOP - Kalamazoo Kalamazoo Michigan 49008 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65802 —
St. John's Regional Health Center Springfield Missouri 65804 —
Hulston Cancer Center at Cox Medical Center South Springfield Missouri 65807 —
Women's Cancer Center - Las Vegas Las Vegas Nevada 89102 —
UMDNJ University Hospital Newark New Jersey 07103 —
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043 —
SUNY Downstate Medical Center Brooklyn New York 11203 —
Stony Brook University Cancer Center Stony Brook New York 11794-8174 —
Hope A Women's Cancer Center Asheville North Carolina 28801 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina 28232-2861 —
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096 —
McDowell Cancer Center at Akron General Medical Center Akron Ohio 44307 —
Case Comprehensive Cancer Center Cleveland Ohio 44106 —
MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland Ohio 44109 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
CCOP - Dayton Dayton Ohio 45429 —
Oklahoma University Medical Center Oklahoma City Oklahoma 73104 —
Cancer Care Associates - Midtown Tulsa Tulsa Oklahoma 74104 —
Williamette Gynecologic Oncology PC Salem Oregon 97301 —
Rosenfeld Cancer Center at Abington Memorial Hospital Abington Pennsylvania 19001 —
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown Pennsylvania 18105 —
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104-4283 —
Fox Chase Cancer Center - Philadelphia Philadelphia Pennsylvania 19111-2497 —
Baptist Regional Cancer Center at Baptist Hospital of East Tennessee Knoxville Tennessee 37901 —
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas 75390 —
M.D. Anderson Cancer Center at University of Texas Houston Texas 77030-4009 —
Massey Cancer Center at Virginia Commonwealth University Richmond Virginia 23298-0037 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087087, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2014 · Synced Sep 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00087087 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →